960 resultados para Sauk Indians
Resumo:
http://www.archive.org/details/diaryofdavid01zeisrich http://www.archive.org/details/diaryofdavid02zeisrich
Forty years among the Indians ; a descriptive history of the long and busy life of Jeremiah Hubbard.
Resumo:
http://www.archive.org/details/fortyyearsamongi00hubbrich
Resumo:
http://www.archive.org/details/ourlifeamongiroq00caswiala
Resumo:
http://www.archive.org/details/upanddownnorth00crosrich
Resumo:
http://name.umdl.umich.edu/ABB4262
Resumo:
http://www.archive.org/details/accountoflifeofm00brairich
Resumo:
http://www.archive.org/details/northoregonind00amerrich
Resumo:
http://www.archive.org/details/missionpima00amonrich
Resumo:
http://www.archive.org/details/bycanoedogtraina00younrich
Resumo:
http://www.archive.org/details/samsonoccom00loverich/
The clear sunshine of the gospel breaking forth upon the Indians in New-England / by Thomas Shepard.
Resumo:
http://www.archive.org/details/clearsunshineofg00sheprich
Resumo:
University of California Libraries
Resumo:
BACKGROUND: With the globalization of clinical trials, large developing nations have substantially increased their participation in multi-site studies. This participation has raised ethical concerns, among them the fear that local customs, habits and culture are not respected while asking potential participants to take part in study. This knowledge gap is particularly noticeable among Indian subjects, since despite the large number of participants, little is known regarding what factors affect their willingness to participate in clinical trials. METHODS: We conducted a meta-analysis of all studies evaluating the factors and barriers, from the perspective of potential Indian participants, contributing to their participation in clinical trials. We searched both international as well as Indian-specific bibliographic databases, including Pubmed, Cochrane, Openjgate, MedInd, Scirus and Medknow, also performing hand searches and communicating with authors to obtain additional references. We enrolled studies dealing exclusively with the participation of Indians in clinical trials. Data extraction was conducted by three researchers, with disagreement being resolved by consensus. RESULTS: Six qualitative studies and one survey were found evaluating the main themes affecting the participation of Indian subjects. Themes included Personal health benefits, Altruism, Trust in physicians, Source of extra income, Detailed knowledge, Methods for motivating participants as factors favoring, while Mistrust on trial organizations, Concerns about efficacy and safety of trials, Psychological reasons, Trial burden, Loss of confidentiality, Dependency issues, Language as the barriers. CONCLUSION: We identified factors that facilitated and barriers that have negative implications on trial participation decisions in Indian subjects. Due consideration and weightage should be assigned to these factors while planning future trials in India.
Resumo:
BACKGROUND: With the global expansion of clinical trials and the expectations of the rise of the emerging economies known as BRICs (Brazil, Russia, India and China), the understanding of factors that affect the willingness to participate in clinical trials of patients from those countries assumes a central role in the future of health research. METHODS: We conducted a systematic review and meta-analysis (SRMA) of willingness to participate in clinical trials among Brazilian patients and then we compared it with Indian patients (with results of another SRMA previously conducted by our group) through a system dynamics model. RESULTS: Five studies were included in the SRMA of Brazilian patients. Our main findings are 1) the major motivation for Brazilian patients to participate in clinical trials is altruism, 2) monetary reimbursement is the least important factor motivating Brazilian patients, 3) the major barrier for Brazilian patients to not participate in clinical trials is the fear of side effects, and 4) Brazilian patients are more likely willing to participate in clinical trials than Indians. CONCLUSION: Our study provides important insights for investigators and sponsors for planning trials in Brazil (and India) in the future. Ignoring these results may lead to unnecessary fund/time spending. More studies are needed to validate our results and for better understanding of this poorly studied theme.